Corporate Events & Conferences

Abivax will be hosting a webcast on Monday, April 8, 2024, at 2:30 p.m. CEST (8:30 a.m. EST) following the announcement of the 2023 yearly results.

The Abivax management will give an overview of the Company’s 2023 highlights and ongoing projects, followed by a live Q&A session.

Please click here to listen in. Please note that you will not be able to ask questions via this link.

If you would like to ask questions during the webcast, please register here  and use the corresponding dial-in numbers or the call back option.

Abivax sponsored a scientific symposium at the ECCO'24 Congress entitled “Expanding the Armamentarium: Emerging MOAs for Treating Ulcerative Colitis” featuring speakers Prof. Bruce E. Sands, M.D., M.S. (United States), and Prof. Raja Atreya, M.D. (Germany), on February 23, 2024.

The replay of the symposium is now publicly available.

Abivax organized a virtual KOL Investor Event on Tuesday, February 6, 2024, at 2:00 p.m. EST (8:00 p.m. CET). The webcast replay of the event is available here.

The event featured Marla Dubinsky, MD, and Parambir Dulai, MD. Along with Abivax’s management, they discussed the unmet medical need and current treatment landscape for patients suffering from ulcerative colitis (UC).

For more information, please read our press release.